---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-040005"
form_type: "8-K"
ticker: "BTMD"
cik: "0001819253"
company_name: "biote Corp."
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T23:18:30.221510+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biote settles founder litigation, to repurchase 18.4M shares for $76.9M at $4.17 each

## Summary
- Repurchases 5.1M Class A shares and 13.3M Paired Interests from founder Donovitz for $76.9M total.
- Average price $4.17 per share; payments spread over three years: $32.2M now, $15.1M, $19.1M, $10.5M.
- Mutual release of all claims; founder advisory agreement terminated, two-year non-compete agreed.
- Existing $20M share repurchase authorization remains separate and unchanged.
- CEO says resolution ends costly litigation and the buyback is accretive to shareholder value.

## SEC filing metadata
- accession: 0001193125-24-040005
- form_type: 8-K
- ticker: BTMD
- cik: 0001819253
- company_name: biote Corp.
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/0001193125-24-040005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/d676367d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-040005
- JSON: https://secwatch.observer/filing/0001193125-24-040005.json
- Plain text: https://secwatch.observer/filing/0001193125-24-040005.txt

## Key facts
- Material Agreements
  biote Corp. entered into Settlement Term Sheet with Dr. Gary S. Donovitz valued at approximately $76.9 million (effective 2024-02-13).
  - Action: entry
  - Agreement: settlement
  - Counterparty: Dr. Gary S. Donovitz
  - Value: approximately $76.9 million
  - Effective: 2024-02-13
  source text: On February 13, 2024, biote Corp., a Delaware corporation (the “Company”) entered into a binding settlement term sheet (the “Settlement Term Sheet”) with respect to its previously disclosed litigation with one of the Company’s stockholders, Dr. Gary S. Donovitz (“Donovitz”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819253/000119312524040005/0001193125-24-040005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.